ReviewFrontiers in oncology2021

Breast Cancer Resistance to Cyclin-Dependent Kinases 4/6 Inhibitors: Intricacy of the Molecular Mechanisms.

Bin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.